Joining the IPO rush, drug maker Alkem Laboratories plans to raise an estimated Rs 1,500-3,500 crore through an initial public offering in one of the biggest offerings in the pharma space in a long time.
Confident of a revival in the initial public offering market (IPO), Securities and Exchange Board of India chairman U K Sinha said companies and their merchant bankers had become much more responsible with pricing and a strong pipeline was building up for
Syngene International, the contract research services arm of Biocon, the Bengaluru-based biopharmaceutical company, announced the launch on Thursday of an Initial Public Offer of its equity.An IPO is a process wherein people can buy shares in a company.
China's move to halt new company listings on its stock markets is offering private equity firms, hedge funds and sovereign wealth funds an opening to fill private companies' funding needs, paving the way for more M&A activity.
Toronto-based Caldwell Securities chose India over China in 2007, buying about five per cent of what was then the Bombay Stock Exchange. Eight years later, Chairman Thomas Caldwell is frustrated because he has few exit options.
Ahmedabad-based Infibeam Incorporation Limited has filed a Draft Red Herring Prospectus (DRHP) with Sebi for an initial public offering (IPO) of equity shares of Rs 10 each for cash including a share premium on per equity basis aggregating up to Rs 450
InterGlobe Aviation, which operates IndiGo, India's largest and most profitable airline, on Tuesday filed a draft red herring prospectus with the Securities and Exchange Board of India (Sebi) to raise Rs 1,272 crore through fresh issue of equity in an